Standardized Long Term Follow-up of Patients After Endovascular Embolization of a Brain Aneurysm
Launched by FONDATION OPHTALMOLOGIQUE ADOLPHE DE ROTHSCHILD · Aug 22, 2016
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is focused on understanding the long-term effects of a treatment called endovascular embolization for patients with brain aneurysms. An aneurysm is a weak spot in a blood vessel in the brain that can bulge and potentially cause serious health issues. The researchers want to gather consistent information over time about how these patients are doing after their treatment, specifically looking to see if the aneurysm comes back or if they need more procedures in the future.
To participate in this study, you need to be at least 18 years old and have undergone successful embolization for a brain aneurysm. There are no specific exclusions, so if you meet these criteria, you may be eligible. If you join the trial, you can expect to provide follow-up information about your health over time. This study is currently recruiting participants, and your involvement could help improve care and understanding for future patients with brain aneurysms.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • curative embolization of a brain aneurysm
- • age \>18 years old
- Exclusion Criteria:
- • none
About Fondation Ophtalmologique Adolphe De Rothschild
The Fondation Ophtalmologique Adolphe de Rothschild is a leading French institution dedicated to advancing ophthalmic research and patient care. Renowned for its commitment to innovation in eye health, the foundation conducts cutting-edge clinical trials aimed at improving treatments for various ocular conditions. With a multidisciplinary team of experts, the foundation collaborates with academic and industry partners to enhance understanding of eye diseases and develop novel therapeutic solutions, ultimately striving to improve patient outcomes and quality of life in ophthalmology.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Paris, , France
Patients applied
Trial Officials
Raphaël Blanc, MD
Principal Investigator
Fondation Ophtalmologique Adolphe de Rothschild
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials